6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Morphine
To treat really painful conditions, morphine is used. It occurs naturally as a dark brown resin in the opiate-family poppy (Papaver somniferum). It acts directly on the central nervous system (CNS) and can be given orally, sublingually, intravenously, subarachnoid, intramuscularly, intravertebral, transdermal, or through rectal suppositories. By exerting a direct influence on the central nervous system, it causes analgesia, changes the perception of the pain and affects how people feel about it. It might become physically and physiologically tolerant of repeated administration. It is widely used for the pain associated with a myocardial infraction, kidney stones, labour pain, and severe pain. It is utilised for both acute and chronic pain. Side effects of Morphine include:
- Decrease respiratory effort
- Nausea and Vomiting
- Low Blood pressure
- Addiction and prone to abuse
- Drowsiness, etc.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States